Abstract:We previously developed several successful decellularization strategies that yielded porcine cardiac extracellular matrices (pcECMs) exhibiting tissue-specific bioactivity and bioinductive capacity when cultured with various pluripotent and multipotent stem cells. Here, we study the tissue-specific effects of the pcECM on seeded human mesenchymal stem cell (hMSC) phenotypes using reverse transcribed quantitative polymerase chain reaction (RT-qPCR) arrays for cardiovascular related gene expression. We further corroborated interesting findings at the protein level (flow cytometry and immunological stains) as well as bioinformatically using several mRNA sequencing and protein databases of normal and pathologic adult and embryonic (organogenesis stage) tissue expression. We discovered that upon the seeding of hMSCs on the pcECM, they displayed a partial mesenchymal-to-epithelial transition (MET) toward endothelial phenotypes (CD31+) and morphologies, which were preceded by an early spike (~Day 3 onward after seeding) in HAND2 expression at both the mRNA and protein levels compared to that in plate controls. The CRISPR-Cas9 knockout (KO) of HAND2 and its associated antisense long non-coding RNA (HAND2-AS1) regulatory region resulted in proliferation arrest, hypertrophy, and senescent-like morphology. Bioinformatic analyses revealed that HAND2 and HAND2-AS1 are highly correlated in expression and are expressed in many different tissue types albeit at distinct yet tightly regulated expression levels. Deviation (downregulation or upregulation) from these basal tissue expression levels is associated with a long list of pathologies. We thus suggest that HAND2 expression levels may possibly fine-tune hMSCs' plasticity through affecting senescence and mesenchymal-to-epithelial transition states, through yet unknown mechanisms. Targeting this pathway may open up a promising new therapeutic approach for a wide range of diseases, including cancer, degenerative disorders, and aging. Nevertheless, further investigation is required to validate these findings and better understand the molecular players involved, potential inducers and inhibitors of this pathway, and eventually potential therapeutic applications.

The level of HAND1 controls the specification of multipotent cardiac and extraembryonic progenitors

HAND factors regulate cardiac lineage commitment and differentiation from human pluripotent stem cells

Pioneering function of Isl1 in the epigenetic control of cardiomyocyte cell fate.

Epicardioid Single-Cell Genomics Uncovers Principles of Human Epicardium Biology in Heart Development and Disease

Expression dynamics of HAND1/2 in in vitro human cardiomyocyte differentiation

Single-cell reconstruction of differentiation trajectory reveals a critical role of ETS1 in human cardiac lineage commitment

Epigenetic delineation of the earliest cardiac lineage segregation by single-cell multi-omics

Single-cell multi-modal integrative analyses highlight functional dynamic gene regulatory networks directing human cardiac development

The Lncrna Hand2os1/Uph Locus Orchestrates Heart Development Through Regulation of Precise Expression of Hand2

Integrated multi-omics analysis identifies features that predict human pluripotent stem cell-derived progenitor differentiation to cardiomyocytes

The generation and validation of a dual cardiac HAND1-Tomato NKX2-5-GFP human embryonic stem cell line UMANe002-A-3

Distinct HAND2/HAND2-AS1 Expression Levels May Fine-Tune Mesenchymal and Epithelial Cell Plasticity of Human Mesenchymal Stem Cells

Islet1 Progenitors in Developing and Postnatal Heart

Transient stabilization of human cardiovascular progenitor cells from hPSCs in vitro reflects stage-specific heart development in vivo

Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells.

Cooperative Regulation of Zhx1 and Hnrnpa1 Drives the Cardiac Progenitor-Specific Transcriptional Activation During Cardiomyocyte Differentiation

Single-Cell Transcriptomic Analysis of Cardiac Progenitor Differentiation

A comprehensive gene expression analysis at sequential stages of in vitro cardiac differentiation from isolated MESP1-expressing-mesoderm progenitors

Multipotent embryonic isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification.

HBL1 is a Human Long Noncoding RNA That Modulates Cardiomyocyte Development from Pluripotent Stem Cells by Counteracting MIR1

Human pluripotent stem cell fate trajectories toward lung and hepatocyte progenitors